Back
Rapt Therapeutics, Inc. Stock Price Chart
Exxon and Chevron Have an Unlikely New Competitor
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
41
RAPT
Rapt Therapeutics, Inc.
Last Price:
$34.99
Seasonality Move:
-37.09%
7 Day Trial
ALL ACCESS PASS
$
7
The Next Gold Rush
DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RAPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
Rapt Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.47 | Buy |
| 20-day SMA: | 33.71 | Buy |
| 50-day SMA: | 32.3 | Buy |
| 200-day SMA: | 18.24 | Buy |
| 8-day EMA: | 33.66 | Buy |
| 20-day EMA: | 33.46 | Buy |
| 50-day EMA: | 31.91 | Buy |
| 200-day EMA: | 24.03 | Buy |
Rapt Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 55.12 | Buy |
| Chaikin Money Flow: | 338413 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (32.13 - 35.61) | Buy |
| Bollinger Bands (100): | (20.67 - 34.87) | Buy |
Rapt Therapeutics, Inc. Technical Analysis
| Jan 5 | Jan 6 | Jan 7 | Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Rapt Therapeutics, Inc. Stock
Is Rapt Therapeutics, Inc. Stock a Buy?
-
Rapt Therapeutics, Inc. share price is 35.10 while RAPT 8-day simple moving average is 33.47, which is a Buy signal.
-
The stock price of RAPT is 35.10 while Rapt Therapeutics, Inc. 20-day SMA is 33.71, which makes it a Buy.
-
Rapt Therapeutics, Inc. 50-day simple moving average is 32.30 while RAPT share price is 35.10, making it a Buy technically.
-
RAPT stock price is 35.10 and Rapt Therapeutics, Inc. 200-day simple moving average is 18.24, creating a Buy signal.
RAPT Technical Analysis vs Fundamental Analysis
Sell
41
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Is Rapt Therapeutics, Inc. a Buy or a Sell?
-
Rapt Therapeutics, Inc. stock is rated a SellThe current Rapt Therapeutics, Inc. [RAPT] share price is $35.10. The Score for RAPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
Rapt Therapeutics, Inc. Stock Info
Market Cap:
580.5M
Price in USD:
35.10
Share Volume:
430.1K
Rapt Therapeutics, Inc. 52-Week Range
52-Week High:
42.39
52-Week Low:
5.67
Sell
41
Rapt Therapeutics, Inc. (RAPT)
is a Sell
Rapt Therapeutics, Inc. Share Price Forecast
-
What is the Rapt Therapeutics, Inc. stock price today?The Rapt Therapeutics, Inc. stock price is 35.10 USD today.
-
Will RAPT stock go up or go down?Rapt Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Rapt Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Rapt Therapeutics, Inc. is overvalued.
Is Rapt Therapeutics, Inc. Stock a Buy?
-
Rapt Therapeutics, Inc. share price is 35.10 while RAPT 8-day exponential moving average is 33.66, which is a Buy signal.
-
The stock price of RAPT is 35.10 while Rapt Therapeutics, Inc. 20-day EMA is 33.46, which makes it a Buy.
-
Rapt Therapeutics, Inc. 50-day exponential moving average is 31.91 while RAPT share price is 35.10, making it a Buy technically.
-
RAPT stock price is 35.10 and Rapt Therapeutics, Inc. 200-day simple moving average is 24.03, creating a Buy signal.
Fundamental Analysis of Rapt Therapeutics, Inc.
Is Rapt Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.05 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and a decrease next year of $1.06 per share.
Technical Analysis of Rapt Therapeutics, Inc.
Should I short Rapt Therapeutics, Inc. stock?
-
RAPT Moving Average Covergence Divergence (MACD) indicator is 0.25, suggesting Rapt Therapeutics, Inc. is a Buy
-
Rapt Therapeutics, Inc. Relative Strength Index (RSI) is 55.12, which suggest Rapt Therapeutics, Inc. is overbought
-
The Bollinger Bands (25) for Rapt Therapeutics, Inc. is (32.13 - 35.61), which suggest Rapt Therapeutics, Inc. is a Buy
-
The Bollinger Bands (100) for Rapt Therapeutics, Inc. is (20.67 - 34.87), which suggest Rapt Therapeutics, Inc. is a Buy
* Rapt Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.